Two research grants worth a total of almost $7 million have been awarded to NSW research groups in the latest injection from the NSW Government’s translational cancer research program.

 

The grants, administered by the Cancer Institute of NSW, have been awarded to the Asbestos Diseases Research Institute (ADRI) and the ANZAC Research Institute, based at the Concord Repatriation General Hospital in Sydney.

 

The ADRI, group led by director Professor Nico van Zandwijk, has been awarded $3.5 million to improve outcomes for people with asbestos-related cancer and their families. 

 

A team working at the Anzac Research Institute and the University of Sydney, led by Professor Derek Hart, has been awarded $3.47 million for the diagnosis and treatment of blood cancers.

 

The wider research grants program awarded by the Cancer Institute of NSW also includes $4.3 million in fellowships, attracting new cancer researchers to NSW and supporting current researchers to develop and present their work on the international stage.